Skip to main content
Clinical Trials/NCT07227038
NCT07227038RecruitingNot Applicable

Living Well With Advanced Breast Cancer

Ohio State University Comprehensive Cancer Center1 site in 1 country50 target enrollmentStarted: January 13, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
50
Locations
1
Primary Endpoint
Acceptability of current LWABC (Living Well with Advanced Breast Cancer) model

Study Overview

Brief Summary

This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.

Detailed Description

PRIMARY OBJECTIVES:

I. Assess acceptability of current LWABC model. II. Conduct a comprehensive review of participants' medical history, treatment records, and demographic data.

III. Explore differences in survivorship care engagement across four distinct cohorts.

OUTLINE: This is an observational study.

Participants complete a survey and a semi-structured interview on study.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •* COHORT 1:
  • •Diagnosis of stage 4 metastatic breast cancer within the past 5 years
  • •Never been referred to the LWABC
  • •Adults age ≥ 18 years
  • •COHORT 2:
  • •Diagnosis of stage 4 metastatic breast cancer within the past 5 years
  • •Have cancelled an appointment with the LWABC
  • •Adults age ≥ 18 years
  • •COHORT 3:
  • •Been seen in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC) within the past 5 years
  • •Completed an appointment with the LWABC
  • •Adults age ≥ 18 years
  • •COHORT 4:
  • •Caregivers for ABC patients
  • •Adults age ≥ 18 years

Exclusion Criteria

  • •Patients who cannot provide own informed consent

Arms & Interventions

Observational

Patients complete a survey and a semi-structured interview on study.

Intervention: Non-Interventional Study (Other)

Outcomes

Primary Outcomes

Acceptability of current LWABC (Living Well with Advanced Breast Cancer) model

Time Frame: Up to study completion, up to 1 day

Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Participant medical history, treatment records, and demographic data

Time Frame: Up to study completion, up to 1 day

Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items including demographic information and disease characteristics will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Differences in survivorship care engagement across four distinct cohorts

Time Frame: Up to study completion, up to 1 day

Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Themes will be compared across each cohort to identify survivorship care needs that will be translated into intervention components for the ABC survivorship program. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ashley Davenport

Principal Investigator

Ohio State University Comprehensive Cancer Center

Study Sites (1)

Loading locations...

Similar Trials

Living Well With Advanced Breast Cancer | Clinical Trial